Arcutis Biotherapeutics Inc.

09/26/2022 | Press release | Distributed by Public on 09/26/2022 06:07

Arcutis Announces Positive Topline Results from ARRECTOR Pivotal Phase 3 Trial of Roflumilast Foam 0